- 1121 E Broadway St, Ste 129, Missoula, MT, 59802
- 406-541-5913
© Copyright 2022 Inimmune. All Rights Reserved.
TLR-7/8 (INI-4001), TLR-4 (INI-2002), CTLR (UM-1098), STING
Seasonal Allergic Rhinitis, Food Allergy
TLR-7/8 agonist (INI-4001), CTLR agonist, STING Agonist
Pseudomonas vaccine, MRSA antibiotics, NSR
Anti-Opioid Vaccine, Pseudomonas vaccine
Autoimmune Disease (expands directly to the general write-up that JH provided)
Inimmune is advancing a novel TLR7/8 agonist nanoparticle formulation to the clinic to treat cancer by harnessing the patient’s immune system and synergizing with existing immune checkpoint inhibitor therapies. Further, we’re leveraging our expertise in innate immune activation to develop novel compounds and technology to target other immune receptors to develop the next generation of disruptive therapies in oncology.
Professional doctor or nurse giving flu or COVID-19 injection to patient. Woman in medical face mask getting antiviral vaccine at hospital or health center during vaccination and immunization campaign.
Seasonal Allergic Rhinitis, Food Allergy
TLR-7/8 (INI-4001), TLR-4 (INI-2002), CTLR (UM-1098), STING
Pseudomonas vaccine, MRSA antibiotics, NSR
Anti-Opioid Vaccine, Pseudomonas vaccine
Autoimmune Disease (expands directly to the general write-up that JH provided)